Literature DB >> 2111736

Increased production of reactive oxygen species by cells from mice acutely infected with Trypanosoma cruzi.

R L Cardoni1, M E Rottenberg, E L Segura.   

Abstract

Release of reactive oxygen species (ROS) by cells from BALB/c mice was studied during the acute stage of the infection with 50 bloodstream forms of Trypanosoma cruzi, Tulahuén strain. Production of ROS by spleen and peritoneal cells was evaluated by chemiluminescence using luminol as enhancer (CL-Lum). Three to four weeks after infection, CL-Lum response after the addition of opsonized zymosan to spleen and peritoneal cells from infected mice was 13 and 98 times, respectively, above the levels obtained with cells from noninfected mice. The kinetics of this hyperactivity was similar to that of the parasitemia. Both reached maximal values on the third to fourth weeks and decreased at 7 weeks postinfection. During this hyperactivation stage, spleen and peritoneal cells from infected mice showed a "spontaneous" CL-Lum response (without any stimulus added in vitro) absent in noninfected mice. Both, "spontaneous" and zymosan stimulated CL-Lum responses were inhibited by 100 microM azide and by 0.8 microM superoxide dismutase, suggesting the involvement of hemoproteins and superoxide anion in the measured responses. Moreover, spleen cells from acutely infected mice displayed a hyperactivity in the CL-Lum response when recombinant interferon-gamma was added in vitro. Supernatants of spleen cells from both normal or infected mice, stimulated in vitro with concanavalin A, contained similar levels of interferon and were equally able to stimulate the trypanocidal activity of normal macrophages. These results suggest that mediators of activation of phagocytic cells can be produced during acute T. cruzi infection. In addition, phagocytic cells from acutely infected mice were activated in vivo and were hyperactive to the in vitro stimulation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2111736     DOI: 10.1016/0008-8749(90)90002-9

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  8 in total

1.  Trypanosoma cruzi infection in tumor necrosis factor receptor p55-deficient mice.

Authors:  E Castaños-Velez; S Maerlan; L M Osorio; F Aberg; P Biberfeld; A Orn; M E Rottenberg
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

2.  Trypanosoma cruzi induces the reactive oxygen species-PARP-1-RelA pathway for up-regulation of cytokine expression in cardiomyocytes.

Authors:  Xueqing Ba; Shivali Gupta; Mercy Davidson; Nisha Jain Garg
Journal:  J Biol Chem       Date:  2010-02-09       Impact factor: 5.157

3.  Trypanosoma cruzi: enhanced alpha-macroglobulin levels correlate with the resistance of BALB/cj mice to acute infection.

Authors:  T C Araujo-Jorge; M J Lage; M T Rivera; Y Carlier; F Van Leuven
Journal:  Parasitol Res       Date:  1992       Impact factor: 2.289

4.  Induction of Effective Immunity against Trypanosoma cruzi.

Authors:  Tere Williams; Ignacio Guerrero-Ros; Yanfen Ma; Fabiane Matos Dos Santos; Philipp E Scherer; Ruth Gordillo; Aline Horta; Fernando Macian; Louis M Weiss; Huan Huang
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

5.  Diet Modulates Adipose Tissue Oxidative Stress in a Murine Acute Chagas Model.

Authors:  Janeesh Plakkal Ayyappan; Jyothi F Nagajyothi
Journal:  JSM Atheroscler       Date:  2017-03-21

6.  P47phox-/- mice are compromised in expansion and activation of CD8+ T cells and susceptible to Trypanosoma cruzi infection.

Authors:  Monisha Dhiman; Nisha Jain Garg
Journal:  PLoS Pathog       Date:  2014-12-04       Impact factor: 6.823

7.  A terpenoid-rich extract from Clethra fimbriata exhibits anti-Trypanosoma cru zi activity and induces T cell cytokine production.

Authors:  Daniel Pardo-Rodriguez; Paola Lasso; José Mateus; John Mendez; Concepción J Puerta; Adriana Cuéllar; Jorge Robles; Claudia Cuervo
Journal:  Heliyon       Date:  2022-03-25

Review 8.  Gasdermins in Innate Host Defense Against Entamoeba histolytica and Other Protozoan Parasites.

Authors:  Shanshan Wang; France Moreau; Kris Chadee
Journal:  Front Immunol       Date:  2022-06-20       Impact factor: 8.786

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.